Hopes build for new Novartis heart failure drug

August 5, 2014 12:02 PM

12 0

Hopes build for new Novartis heart failure drug

LONDON (Reuters) - Expectations are building for a new heart failure drug from Novartis viewed as a likely multibillion-dollar seller, with two surveys of cardiologists published on Tuesday highlighting its potential.

A large clinical trial with LCZ696 was stopped early in March because the benefit to patients was overwhelmingly positive. Just how good the drug was will be disclosed at a medical meeting in Spain at the end of this month.

Read more

To category page

Loading...